ELFBAR 1200, 2-in-1 Double-Pod Vape, Launched in UK

Elfbar by 2FIRSTS, edited by Sophia
Apr.24.2024
ELFBAR 1200, 2-in-1 Double-Pod Vape, Launched in UK
ELFBAR to launch new product ELFBAR 1200 in UK, featuring "2-IN-1" design and multiple flavor options.

Special Statement:

This article is limited to research on global industrial development and does not make any recommendations regarding brands, products, or investments.

Minors are prohibited from visiting.


 

On April 25th, 2FIRSTS discovered on the official UK website of ELFBAR that they are soon releasing a new product called ELFBAR 1200. While the product is currently listed as "coming soon" and not all information is available, some online e-cigarette stores in the UK have started revealing details. The e-cigarette website vapourcore has announced that the kit price for ELFBAR 1200 will be £6.95.

 

ELFBAR 1200, 2-in-1 Double-Pod Vape, Launched in UK
ELFBAR 1200 | Image source: ELFBAR.UK

 

The popular e-cigarette website VAPEUK introduces the ELFBAR 1200 as a rechargeable pre-filled mini vape kit. In compliance with TPD regulations, it combines a "2-IN-1" feature, claiming to have created a legal 1200-puff disposable device in the UK. It is equipped with a 650 mAh battery, Type-C port, and QUAQ mesh coils.

 

ELFBAR 1200, 2-in-1 Double-Pod Vape, Launched in UK
Product Introduction | Image Source: VAPEUK

 

It is worth noting that the device comes with two pods containing 2% nicotine and 2ml each, totaling up to 1200 puffs. This also means that users can choose two different pods for a flavor mix. It is reported that the ELFBAR 1200 offers 22 flavor options.

 

The main feature of the product is its unique installation method. Unlike a standalone pod system, users must insert the pod into two ports on the device and then attach the mouthpiece, allowing time for the e-liquid to be absorbed before use.

 

Products such as the IVG 2400 and Sky Hunter 2600, which feature a combination of pods to increase capacity, are not uncommon in the UK market. By using multiple pods, these products not only comply with UK regulations but also have a capacity of over 600 puffs.

 

ELFBAR 1200, 2-in-1 Double-Pod Vape, Launched in UK
Installation method | Image source: VAPEUK

 

ELFBAR 1200, 2-in-1 Double-Pod Vape, Launched in UK
Sky Hunter 2600 | Image source: vapourcore

 

The product "ELFBAR 1200" "EB 1200" was searched using the keyword in the e-cigarette search system of the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK. It was found that the product was publicly listed on March 11, and is categorized as a "refillable container/pod filled with electronic liquid." According to UK e-cigarette regulations, this e-cigarette product has been certified and approved by the British government.

 

ELFBAR 1200, 2-in-1 Double-Pod Vape, Launched in UK
Product search | Image source: MHRA

 

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

South Africa health department agrees to exempt smokeless and non-combustible products from tobacco control bill
South Africa health department agrees to exempt smokeless and non-combustible products from tobacco control bill
At a parliamentary committee meeting in South Africa, Health Minister Aaron Motsoaledi said the health department has agreed to exempt non-combustible and smokeless products — including chewing tobacco, snus, nicotine pouches and e-cigarettes — from the Tobacco Products and Electronic Delivery Systems Control Bill. The department is prepared, at this stage, to exempt them from packaging and labelling requirements except for misleading or false claims.
Mar.06 by 2FIRSTS.ai
Kansas Senate approves tougher vape rules to target unlicensed products and child-directed ads
Kansas Senate approves tougher vape rules to target unlicensed products and child-directed ads
The Kansas Senate approved Senate Bill 355 on Wednesday, aiming to crack down on unlicensed vaping products and eliminate advertisements geared toward children. The bill, backed by major tobacco companies, would impose the same licensing and advertising requirements on e-cigarettes as other nicotine products and require every e-cigarette manufacturer doing business in Kansas to obtain a license, with a $2,500 application fee.
Feb.13 by 2FIRSTS.ai
Poland to ban “characterising flavours” in heated tobacco sticks from Jan. 18, 2026
Poland to ban “characterising flavours” in heated tobacco sticks from Jan. 18, 2026
Poland will implement an amended health protection law on January 18, 2026, restricting the availability of tobacco inserts used in heated tobacco devices. The new rules prohibit products with a “characterising flavour,” meaning a clearly noticeable taste or smell other than tobacco, derived from additives and detectable before or during use.
Jan.20 by 2FIRSTS.ai
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
U.S.-based medical startup Qnovia Inc. reported positive results from its first-in-human clinical trial of RespiRx, an inhalable nicotine replacement therapy (NRT) device designed to support smoking cessation.
Innovation
Feb.24
New York Proposal to Tax Nicotine Pouches at 75% Draws Opposition
New York Proposal to Tax Nicotine Pouches at 75% Draws Opposition
A proposal by New York Governor Kathy Hochul to impose a steep tax on nicotine pouches has drawn opposition from law-enforcement officials and business groups, who say it could expand the state’s illicit tobacco market. The measure was included in Hochul’s preliminary two-year USD 260 billion budget plan and would treat nicotine pouches like other tobacco products.
Mar.17 by 2FIRSTS.ai
Rethinking Nicotine Harm Reduction: A Neuroscientist’s Perspective on Scientific Gaps and Future Directions — By Dr. Xin-an Liu
Rethinking Nicotine Harm Reduction: A Neuroscientist’s Perspective on Scientific Gaps and Future Directions — By Dr. Xin-an Liu
After France’s ANSES report on nicotine products and harm reduction, Dr. Xin-an Liu wrote to 2Firsts reassessing the field’s foundations. She argues the debate reveals gaps in evidence on long-term behavioral substitution, addiction pathways and neurobiological impacts, and calls for longitudinal research, integrated behavioral science and neuroimaging, clearer risk assessment and stronger transparency to ensure policy and next-generation product development rest on solid evidence.
Industry Insight
Feb.24